Clinical Audits of Sever pre-eclampsia Management at South Valley University Hospitals

Document Type : Original research articles

Authors

1 Department of Obstetrics and Gynecology Department, Faculty of Medicine South Valley University,Qena, Eygpt

2 Obstetrics and Gynecology Department, Faculty of Medicine ,Al-Azhar University (Assiut Branch), Assiut, Eygpt

Abstract

Background: Clinical audits based on standard criteria have been used in developed countries to improve the management of certain diseases as pre-eclampsia and eclampsia. It has been introduced nowadays in the assessment of diseases indeveloping countries
Objectives:  To assess the management of sever pre-eclampsia in South valley university Hospitals.
Patients and method(s):This clinical audit was conducted on  pregnant women who had sever pre-eclampsia from those admitted to Obstetrics & Gynecology department of South Valley University Hospitals during the period from September 2016 to september2020. Patients were diagnosed as sever preeclampsia according to RCOG criteria 2019.
Results: The study was conducted on 150 patient had severe preeclampsia. The results showed 70% of patients were primigravida and old age, 40% of patients received corticosteroid within 7 day before termination, 50% of patients received Magnesium sulphate, 60% of patients were admitted to ICU. 70% of patients were not terminated before 37weeks.
Conclusion: Learning doctors about symptoms, signs and complication of sever preeclampsia, patient with sever preeclampsia should be admitted to hospital, do investigation 3 time per week. Measurement of blood pressure (BP) every 15-30 minute until BP less than 160/110 then 4 time / day.  Use the suitable antihypertensive drug as labetalol as first line, then nifedipine. Women with sever preeclampsia should admit to ICU. Intravenous sulphate should be taken

Keywords

Main Subjects

SVU-International Journal of Medical Sciences
Volume 5, Issue 2
July 2022
Pages 200-208

Files

Share

How to cite

Statistics